BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2984011)

  • 1. A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy.
    Jefferys D; Boublik J; Funder JW
    Eur J Pharmacol; 1985 Jan; 107(3):331-5. PubMed ID: 2984011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.
    Chahl LA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):387-92. PubMed ID: 2430191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catatonic or hypotonic immobility induced in mice by intracerebroventricular injection of mu or kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation.
    Chaillet P; Marçais-Collado H; Costentin J
    Life Sci; 1983 Nov; 33(21):2105-11. PubMed ID: 6685806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic polypeptide secretion via selective activation of kappa-opioid receptor: role of dynorphin.
    Yamada K; Yoshida S; Shimada Y
    Am J Physiol; 1991 Sep; 261(3 Pt 1):E293-7. PubMed ID: 1716056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of kappa agonist.
    Kumor K; Su TP; Vaupel B; Haertzen C; Johnson RE; Goldberg S
    NIDA Res Monogr; 1986; 67():18-25. PubMed ID: 3018572
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy.
    Jefferys D; Copolov D; Funder JW
    Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M; Junien JL; Bueno L
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM; Haertzen CA; Johnson RE; Kocher T; Jasinski D
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats.
    Leander JD
    Neuropeptides; 1984 Dec; 5(1-3):283-6. PubMed ID: 6099514
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased immunoreactive dynorphin and leu-enkephalin in posterior pituitary of obese mice (ob/ob) and super-sensitivity to drugs that act at kappa receptors.
    Ferguson-Segall M; Flynn JJ; Walker J; Margules DL
    Life Sci; 1982 Nov 15-22; 31(20-21):2233-6. PubMed ID: 6131356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of feeding behaviour in monosodium glutamate (MSG) treated mice.
    Ma V; Ma A; Cameron DP
    Life Sci; 1988; 42(15):1419-24. PubMed ID: 2832677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor types on adrenergic nerve terminals of rabbit ear artery.
    Fukuda H; Hosoki E; Ishida Y; Moritoki H
    Br J Pharmacol; 1985 Nov; 86(3):539-45. PubMed ID: 2998521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.